Ni Khin

Ni Khin serves as the Executive Medical Director at Neurocrine Biosciences since April 2021, bringing extensive experience from a 20-year tenure at the FDA, where roles included Division Director of the Division of Clinical Compliance Evaluation and Lead Medical Officer in the Division of Psychiatry Products. Khin's FDA career focused on Good Clinical Practice (GCP) oversight, regulatory compliance, and integration of multidisciplinary reviews for drug approvals. Earlier professional roles included Senior Staff Fellow at the National Institute of Mental Health and Resident Physician at the University at Buffalo, with initial experience as a Research Associate at Orthologic Corporation and Graduate Teaching Assistant at Arizona State University. Khin holds a Doctor of Medicine degree from the Institute of Medicine I and a Master's degree in Microbiology from Arizona State University.